Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
AFGB American Financial Group Inc 5875 Subordinated Debentures due 2059 posts 91 percent Q4 2025 EPS beat shares rise modestly after results Market Recap Technology leads broad gains as consumer sector lags in positive session Is Gladstone LANDP stock underpriced in the market Slight Downtick 20260418 State Street Utilities Select Sector SPDR ETF XLU Top Defensive Q2 2026 Pick Amid Geopolitical Volatility and AI Tailwinds ASTL Algoma Steel posts far wider than expected Q4 2025 loss 254 year over year revenue drop and small share dip Aclarion ACON Stock Insider Buying Eye on Rally 20260420 AI Disruption Impact on CrossSector Equity Valuations When Will Gas Prices Ease Drivers Await Potential Relief at the Pump Zydus Wellness Reports Higher Q4 Profit IOC JSW Cement Astral DOMS Industries Among Companies Set to Announce Results Today Google Gemini Experiment Shows AI Managing a Coffee Shop Driving It Toward Closure OPAL Fuels OPAL Q1 2026 Results Miss Estimates EPS 009 vs 002 SPACSphere SSACW Steady at 007 Awaiting Next Catalyst 20260518 MDA Space MDA Falls 233 Watching 3700 Support 20260519 First Quarter Earnings Reveal a Cautious Consumer Signs of Strain Ahead Qualcomm Launches First Chip for Budget PCs Amid Ongoing Component Shortages Endurance Technologies IPO Opens Company Aims to Raise 1162 Crore via Public Issue Geopolitical Tensions Rise as Gaza Flotilla Detainees Allege Mistreatment by Israeli Forces OpenAIs Potential IPO Filing Signals Intensified Race Among AI Giants to Go Public Kentuckys Commitment to Thoroughbred Racing Solidifies Industry Leadership EFXT Q1 2026 Earnings Earnings Surge Past Estimates by 65 Symbotic SYM Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Optimism VZ Q1 2026 Earnings EPS Beats Estimates by Nearly 4 as Wireless Business Holds Steady Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain Disc Medicine Q1 2026 Earnings NarrowerThanExpected Loss Offsets Lack of Revenue Stock Edges Down Phunware Q1 2026 Earnings EPS Beat on LowerThanExpected Loss Revenue Unreported Apimeds Pharmaceuticals US Inc APUS Continues to Slide Testing Key Support at 129 Flaherty Crumrine Total Return Fund FLC Holds Steady Near Key Support as YieldSeeking Investors Weigh Options Affinity Bancshares AFBI Holds Steady Near Support After Minimal Decline Everus Construction Group ECG Nears Support as Momentum Weakens Constellium SE CSTM Gains 446 as Aluminum Demand Optimism Returns